HCAR1 and epilepsy: The administration of a synthetic HCAR1 agonist failed to modulate seizures in an in vivo epilepsy model, possibly due to competition with elevated endogenous lactate levels during seizures, underscoring the intricate interplay between exogenous and endogenous HCAR1 modulators.